Columbus, Ohio

The Ohio State University Comprehensive Cancer Center– Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) has more than 300 cancer researchers and sub-specialized cancer physicians spanning 12 of the 15 colleges at Ohio State and is one of only four centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs. Treating more than 10,000 patients annually, the center manages hundreds of cancer clinical trials, and holds three prestigious NCI SPORE grants for the study of leukemia, thyroid cancer and sarcoma. In December 2014, The OSUCCC – James opened a transformational 21 floor, 1.1 million square foot, 306-bed cancer hospital that places cancer care operations in close proximity to the institution’s robust research facilities. Working together, clinicians and researchers at the OSUCCC – James are speeding the development and delivery of treatments that target the molecules and markers fueling each person’s unique cancer.